TOKAI PHARMACEUTICALS INC's ticker is TKAI and the CUSIP is 88907J107. A total of 54 filers reported holding TOKAI PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,776,000 | +0.3% | 322,297 | +2.1% | 0.02% | +6.2% |
| Q1 2016 | $1,771,000 | -19.4% | 315,757 | +25.4% | 0.02% | -30.4% |
| Q4 2015 | $2,196,000 | -37.1% | 251,797 | -25.4% | 0.02% | -43.9% |
| Q3 2015 | $3,493,000 | -57.2% | 337,454 | -45.0% | 0.04% | -12.8% |
| Q2 2015 | $8,154,000 | +153.9% | 613,134 | +115.8% | 0.05% | +6.8% |
| Q1 2015 | $3,211,000 | -17.2% | 284,142 | +7.9% | 0.04% | -33.3% |
| Q4 2014 | $3,880,000 | -6.1% | 263,252 | -3.6% | 0.07% | -22.4% |
| Q3 2014 | $4,133,000 | – | 273,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Owl Capital Management, LLC | 132,500 | $1,155,000 | 1.36% |
| Novo Holdings A/S | 470,946 | $4,107,000 | 0.40% |
| Opus Point Partners Management, LLC | 62,007 | $541,000 | 0.36% |
| Perceptive Advisors | 485,338 | $4,232,000 | 0.31% |
| NJ State Employees Deferred Compensation Plan | 35,000 | $305,000 | 0.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 87,983 | $767,000 | 0.04% |
| ROPES WEALTH ADVISORS LLC | 6,000 | $52,000 | 0.02% |
| Alyeska Investment Group, L.P. | 251,797 | $2,196,000 | 0.02% |
| A.R.T. Advisors, LLC | 27,490 | $239,000 | 0.01% |
| ALPS ADVISORS INC | 29,753 | $259,000 | 0.00% |